Januar 2025 $$ Associations between white matter microstructure and cognitive decline in major depressive disorder versus controls in Germany: a prospective case-control cohort study
Journal: Lancet Psychiatry
Autorin: Dr. Susanne Meinert
Institution: Institut für Translationale Psychiatrie, Universität Münster
Dezember 2024 $$ Aggressive Lymphoma after CD19 CAR T-Cell Therapy
Journal: New England Journal of Medicine
Autor: Prof. Dr. Frederik Damm
Institution: Charité – Universitätsmedizin Berlin, Klinik m.S. für Hämatologie, Onkologie und Tumorimmunologie, Campus Virchowklinikum
November 2024: $$ Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients with Hodgkin Lymphoma
Journal: Journal of Clinical Oncology
Autor: Jan-Michel Heger
Institution: Klinik I für Innere Medizin, Uniklinik Köln
Oktober 2024: $$ Monitoring Patients with Glioblastoma by Using a Large Language Model: Accurate Summarization of Radiology Reports with GPT-4
Journal: Radiology
Autor: Kai Roman Laukamp
Institution: Institut für Diagnostische und Interventionelle Radiologie, Uniklinik Köln
August 2024: $$ STING orchestrates the neuronal inflammatory stress response in multiple sclerosis
Journal: Cell 2024
Autor: Marcel S. Woo
Institution: Institut für Neuroimmunologie und Multiple Sklerose, Universitätsklinikum Hamburg-Eppendorf
Juli 2024: $$ Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation
Journal: Nature Cancer 2024
Autoren: Erik Thiele Orberg und Elisabeth Meedt
Institution: Technische Universität München (ETO) und Universitätsklinikum Regensburg (EM)
Juni 2024: $$ Multiomic analyses uncover immunological signatures in acute and chronic coronary syndromes
Journal: Nature Medicine 2024
Autor: Dr. Kami Pekayvaz
Institution: Medizinische Klinik I, LMU Klinikum
Mai 2024: $$ Multimodal layer modelling reveals in vivo pathology in amyotrophic lateral sclerosis
Journal: Brain 2024
Autorin: Esther Kühn
Institution: Hertie Institut für Klinische Hirnforschung
April 2024: $$ The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma
Journal: Nature Communications 2024
Autor: Dr. Stephan Spahn
Institution: Innere Medizin I, Universitätsklinikum Tübingen
März 2024: $$ Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA
Journal: Blood 2024
Autor: Dr. Jan-Michel Heger
Institution: Klinik I für Innere Medizin, Uniklinik Köln